Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts

Cancer Science

Volumn 102, Issue 8, 2011, Pages 1545-1552

  Naganuma, Yasuko ^a   Choijamts, Batsuren ^a   Shirota, Kyoko ^a   Nakajima, Kyoko ^a   Ogata, Shigenori ^a   Miyamoto, Shingo ^a   Kawarabayashi, Tatsuhiko ^a   Emoto, Makoto ^a,b  

^a FUKUOKA UNIVERSITY   (Japan)

^b FUKUOKA SANNO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXIFLURIDINE; FUMAGILLOL CHLOROACETYLCARBAMATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER THERAPY; COCULTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINAL BLEEDING; METRONOMIC CHEMOTHERAPY; MICROVASCULATURE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN; UTERUS CARCINOMA; UTERUS CARCISARCOMA; UTERUS SARCOMA; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOSARCOMA; CELL LINE, TUMOR; CYCLOHEXANES; ENDOTHELIAL CELLS; FEMALE; FLOXURIDINE; HUMANS; MICE; MICE, INBRED BALB C; SESQUITERPENES; THROMBOSPONDIN 1; THYMIDINE PHOSPHORYLASE; UTERINE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960411251     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01998.x     Document Type: Article

References (34)

1. Sartori E, Bazzurini L, Gadducci A et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 1997; 67: 70-5.
2. Miller BE, Blessing JA, Stehman FB et al. A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 2010; 118: 139-44.
3. Emoto M, Iwasaki H, Ishiguro M et al. Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements. Hum Pathol 1999; 30: 1232-41.
4. Emoto M, Charnock-Jones DS, Licence DR et al. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma. Gynecol Oncol 2004; 95: 474-82.
5. Holash J, Maisonpierre PC, Compton D et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-8.
6. Emoto M, Tachibana K, Iwasaki H, Kawarabayashi T. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color doppler ultrasound. Cancer Sci 2007; 98: 929-35.
7. Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004; 4: 423-36.
8. Pasquier E, Kavallaris M, André N. Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol 2010; 7: 455-65.
9. Doloff JC, Khan N, Ma J, Demidenko E, Swartz HM, Jounaidi Y. Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine. Curr Cancer Drug Targets 2009; 9: 777-88.
10. Bocci G, Falcone A, Fioravanti A et al. Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. Br J Cancer 2008; 98: 1619-29.
11. Blansfield JA, Caragacianu D, Alexander HR3rd et al. Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy. Clin Cancer Res 2008; 14: 270-80.
12. Nagata T, Nakamori M, Iwahashi M, Yamaue H. Overexpression of pyrimidine nucleoside phosphorylase enhances the sensitivity to 5'-deoxy-5-fluorouridine in tumour cells in vitro and in vivo. Eur J Cancer 2002; 38: 712-7.
13. Yoshikawa T, Tsuburaya A, Shimada K et al. A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer 2009; 12: 212-8.
14. Yonekura K, Basaki Y, Chikahisa L et al. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin Cancer Res 1999; 5: 2185-91.
15. Harada K, Supriatno, Kawashima U, Yoshida H, Sato M. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2. Int J Oncol 2007; 30: 365-74.
16. Uehara N, Baba H, Nitta K et al. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors. Jpn J Cancer Res 1985; 76: 1034-41.
17. Bronckaers A, Gago F, Balzarini J, Liekens S. The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev 2009; 29: 903-53.
18. Ingber D, Fujita T, Kishimoto S et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348: 555-7.
19. Benny O, Fainaru O, Adini A et al. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol 2008; 26: 799-807.
20. Muramaki M, Miyake H, Hara I, Kawabata G, Kamidono S. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. J Urol 2004; 172: 1485-9.
21. Emoto M, Naganuma Y, Choijamts B et al. Novel chemoembolization using calcium-phosphate ceramic microsphere incorporating TNP-470, an anti-angiogenic agent. Cancer Sci 2010; 101: 984-90.
22. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993; 53: 2566-70.
23. Shishido T, Yasoshima T, Denno R, Mukaiya M, Sato N, Hirata K. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin. Jpn J Cancer Res 1998; 89: 963-9.
24. Emoto M, Iwasaki H, Kikuchi M et al. Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses. Cancer 1992; 69: 1759-68.
25. Miura S, Emoto M, Matsuo Y, Kawarabayashi T, Saku K. The combination of Jun N-terminal kinase inhibitor and TNP-470 blocks carcinosarcoma-induced endothelial cell tube formation in a synergistic manner. Cancer Lett 2005; 220: 49-55.
26. Opazo Saez AM, Mosel F, Nürnberger J et al. Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability. Br J Clin Pharmacol 2005; 59: 511-9.
27. Kono T, Nishida M, Inagaki N, Tanaka Y, Yoneda M, Kasai S. Development and characterization of 1C6-203, a new monoclonal antibody specific to human thymidine phosphorylase. J Histochem Cytochem 2001; 49: 131-8.
28. Loeffler M, Krüger JA, Reisfeld RA. Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Res 2005; 65: 5027-30.
29. Takebayashi Y, Akiyama S, Akiba S et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88: 1110-7.
30. Ogata Y, Sasatomi T, Mori S et al. Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal carcinoma. Anticancer Res 2007; 27: 2605-11.
31. Wang YQ, Luk JM, Chu AC et al. TNP-470 blockage of VEGF synthesis is dependent on MAPK/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells. Biochem Biophys Res Commun 2006; 341: 239-44.
32. Kruger EA, Figg WD. TNP-470: an angiogenesis inhibitor in clinical development for cancer. Expert Opin Investig Drugs 2000; 9: 1383-96.
33. Satchi-Fainaro R, Mamluk R, Wang L et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005; 7: 251-61.
34. Kiessling F. Science to practice: the dawn of molecular US imaging for clinical cancer imaging. Radiology 2010; 256: 331-3.